What is SDEV's earnings growth forecast for 2026-2026?
(NYSEMKT: SDEV) Stablecoin Development's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
Stablecoin Development's earnings in 2026 is -$86,047,000.
In 2026, SDEV is forecast to generate -$10,510,024 in earnings, with the lowest earnings forecast at -$10,097,867 and the highest earnings forecast at -$10,819,143.
What is SDEV's revenue growth forecast for 2026-2026?
(NYSEMKT: SDEV) Stablecoin Development's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.
Stablecoin Development's revenue in 2026 is $0.
In 2026, SDEV is forecast to generate $438,270,186 in revenue, with the lowest revenue forecast at $421,078,867 and the highest revenue forecast at $451,150,118.
What is SDEV's forecast return on assets (ROA) for 2026-2026?
(NYSEMKT: SDEV) forecast ROA is -5.85%, which is higher than the forecast US Biotechnology industry average of -31.16%.
What is SDEV's Earnings Per Share (EPS) forecast for 2026-2026?
(NYSEMKT: SDEV) Stablecoin Development's current Earnings Per Share (EPS) is -$93.81. In 2026, SDEV's EPS is forecast to hit -$0.39 (min: -$0.37, max: -$0.40).
What is SDEV's forecast return on equity (ROE) for 2026-2026?
(NYSEMKT: SDEV) forecast ROE is -7.57%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.